Admission Date:  [**2101-1-23**]              Discharge Date:   [**2101-2-4**]  Date of Birth:  [**2021-6-21**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Penicillins / Motrin / Naprosyn  Attending:[**First Name3 (LF) 1283**] Chief Complaint: Shortness of breath  Major Surgical or Invasive Procedure: [**2101-1-24**] Mitral valve replacement(27mm [**Company 1543**] Mosaic Porcine) and single vessel coronary artery bypass grafting utilizing the left internal mammary artery to left anterior descending artery.
Based upon the above results, she was transferred to the [**Hospital1 18**] for cardiac surgical intervention.
Prior to transfer, she was started on antibiotics for a urinary tract infection.
Past Medical History: Congestive heart failure, Coronary artery disease - History of Coronary Stents(LAD & RCA) in [**2094**], Mitral regurgitation, Paroxsymal Atrial fibrillation/flutter, Type II Diabetes mellitus; Hypertension, Chronic Obstructive Pulmonary Disease, Hypercholesterolemia, Pulmonary Hypertension; History of GI bleed and Peptic Ulcer Disease, History of Bradycardia - s/p Pacemaker Implantation, Anemia, Hypothyroidism  Social History: Married, lives alone.
Family History: Denies history of premature coronary artery disease  Physical Exam: Admission Vitals: T 98.3, BP 106/50, HR 60, RR 20, SAT 100% on 2L General: elderly female in no acute distress HEENT: oropharynx benign, Neck: supple, no JVD, carotids 2+ without bruits Heart: regular rate, normal s1s2, s3 noted, 3/6 systolic murmur left lower sternal border Lungs: bibasilar rales Abdomen: soft, nontender, normoactive bowel sounds Ext: warm, no edema, no varicosities Pulses: decreased distally Neuro: nonfocal   Pertinent Results: [**2101-2-4**] 06:45AM BLOOD WBC-14.2* RBC-3.42* Hgb-10.5* Hct-32.1* MCV-94 MCH-30.8 MCHC-32.8 RDW-16.1* Plt Ct-300 [**2101-2-4**] 06:45AM BLOOD Plt Ct-300 [**2101-2-4**] 06:45AM BLOOD PT-22.7* PTT-31.1 INR(PT)-2.2* [**2101-2-4**] 06:45AM BLOOD Glucose-119* UreaN-19 Creat-0.8 Na-134 K-4.2 Cl-95* HCO3-28 AnGap-15 [**2101-1-23**] 09:22PM BLOOD ALT-24 AST-25 LD(LDH)-217 AlkPhos-85 TotBili-0.5 [**2101-1-24**] 03:39AM BLOOD ALT-25 AST-24 LD(LDH)-211 AlkPhos-82 TotBili-0.5 [**2101-1-24**] 03:39AM BLOOD %HbA1c-8.1* [Hgb]-DONE [A1c]-DONE [**2101-2-2**] 06:30AM BLOOD TSH-6.2* [**2101-2-2**] 06:30AM BLOOD T4-6.6 T3-77*  [**Hospital1 18**] ECHOCARDIOGRAPHY REPORT  [**Known lastname **], [**Known firstname **]       [**Hospital1 18**] [**Numeric Identifier 70304**] (Complete) Done [**2101-1-24**] at 9:17:37 AM      FINAL Referring Physician     [**Name9 (PRE) **] Information [**Last Name (Prefixes) 413**], [**First Name3 (LF) 412**] Division of Cardiothoracic [**Doctor First Name **] [**First Name (Titles) **] [**Last Name (Titles) **] [**Hospital Unit Name 4081**] [**Location (un) 86**], [**Numeric Identifier 718**]  Status: Inpatient DOB: [**2021-6-21**] Age (years): 79 F  Hgt (in): BP (mm Hg): /  Wgt (lb): HR (bpm):  BSA (m2): Indication: Abnormal ECG.
A catheter or pacing wire is seen in the RA.
The TEE probe was passed with assistance from the anesthesioology staff using a laryngoscope.
The patient was under general anesthesia throughout the procedure.
is AV paced, on phenylephrine and epinephrine drip.
Preserved biventricular systolic function MV - well seated bioprosthetic valve with trace of paravavular leak.
I certify that I was present for this procedure in compliance with HCFA regulations.
The patient is again noted to be status post CABG and mitral valve replacement.
A right- sided dual lead pacer device is in stable position.
DR. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]  DR. [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) 3891**]   Approved: WED [**2101-2-2**] 9:42 AM Procedure Date:[**2101-2-1**]      Brief Hospital Course: Mrs. [**Known lastname **] was admitted directly to the cardiac surgical service and underwent routine preoperative evaluation.
The following day, she underwent a mitral valve replacement and coronary artery bypass grafting by Dr. [**Last Name (STitle) 1290**].
Amiodarone was avoided in setting of Dofetilide therapy.
The EP service was consulted and recommended to increase Dofetilide and monitor QTc intervals by serial ECG.
Intravenous beta blockade was used on a prn basis for rate control.
Given persistent atrial tachycardias, her pacemaker was reprogrammed for some atrial lead undersensing.
She tolerated beta blockade and Dofetilide.
She maintained stable hemodynamics and transferred to the SDU for further care and recovery.
Medications on Admission: Atenolol 25 [**Hospital1 **], Dofetilide 500 mcg [**Hospital1 **], Lisinopril 10 qd, Lasix 40 qd, Glyburide 5 [**Hospital1 **], Glucophage 500 qam and 1000 qpm, Folate, Aspirin 81 qd, Lipitor 20 qd  Discharge Medications: 1.
Furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Potassium Chloride 20 mEq Packet Sig: One (1) Packet PO Q12H (every 12 hours).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed.
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain.
Glyburide 5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Dofetilide 125 mcg Capsule Sig: Three (3) Capsule PO Q12H (every 12 hours).
Metformin 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day).
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Warfarin 2.5 mg Tablet Sig: One (1) Tablet PO once a day: 2 tablets today only [**2-4**]( 5mg dose); then daily dosing per rehab PCP .
Discharge Disposition: Extended Care  Facility: [**Doctor Last Name **] [**Doctor Last Name **] hospital  Discharge Diagnosis: Congestive heart failure, Coronary artery disease, Mitral regurgitation - s/p coronary artery bypass grafing and mitral valve replacement; Paroxsymal Atrial fibrillation/flutter; Type II Diabetes mellitus; Hypertension; COPD; Hypercholesterolemia; Pulmonary Hypertension; History of GI bleed and Peptic Ulcer Disease; History of Coronary Stents(LAD & RCA) in [**2094**]; History of Bradycardia - s/p Pacemaker Implantation, Anemia, Hypothyroidism, Preoperative Urinary Tract Infection   Discharge Condition: Good   Discharge Instructions: Patient may shower, no baths.
No creams, lotions or ointments to incisions.
